Given the importance of CD58 in modulation ofimmune function and the replicated association ofrs12044852 with MS which was confirmed againin this study, we decided to determine the impact ofthis variant on the efficacy of IFN-β therapy and outcomeof treatment for the first time in a prospectivemanner. The gene discussed is IFNB1; the disease is myeloid sarcoma.